FDA Delays Astra's Key Pipeline Drug Brilinta - Toronto Star
 Telegraph.co.uk | FDA Delays Astra's Key Pipeline Drug Brilinta Toronto Star Since Astra is seeking an indication for Brilinta with low-dose aspirin, we believe the drug will eventually reach the US market. U.S. Delays Approval for Astra's Brilinta Astra shares dealt regulatory blow Sector Movers: Astra drags down pharma sector |
Source: news.google.com
0 Responses to "FDA Delays Astra's Key Pipeline Drug Brilinta - Toronto Star (Auchencairn VAUXHALL DEALERS)"
Post a Comment